Previous close | 0.4930 |
Open | 0.4865 |
Bid | 0.5002 x 300 |
Ask | 0.5068 x 200 |
Day's range | 0.4600 - 0.5055 |
52-week range | 0.2900 - 1.7800 |
Volume | |
Avg. volume | 2,445,266 |
Market cap | 104.37M |
Beta (5Y monthly) | 1.35 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings date | 25 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.50 |
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING